Keigo Okada
Ome, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.
Journal: British journal of haematology
Published: February 21, 2026
Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group.
Journal: International journal of hematology
Published: July 14, 2025
Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM database.
Journal: International journal of hematology
Published: June 06, 2025
Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 10, 2023
Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.
Journal: British journal of haematology
Published: October 11, 2023
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis.
Journal: Cancer science
Published: March 26, 2023
Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: September 06, 2022
Perioperative management of laparoscopic cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab treatment
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 01, 2022
A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cell‑surface proteins on target cells.
Journal: International journal of molecular medicine
Published: November 05, 2021
Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma.
Journal: Clinical case reports
Published: August 14, 2021
Severe Motor Weakness Due to Disturbance in Peripheral Nerves Following Tisagenlecleucel Treatment.
Journal: In vivo (Athens, Greece)
Published: July 16, 2021
Last Updated: 09/26/2026